Attached files

file filename
EX-99.2 - EXHIBIT 99.2 - HESKA CORPex992scilauditedfinancia.htm
EX-23.1 - EXHIBIT 23.1 - HESKA CORPexhibit231-bdoconsent.htm
8-K/A - 8-K/A - HESKA CORPheska-8kascilacquisitionfi.htm
Exhibit 99.3

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Introduction
On April 1, 2020, Heska Corporation (“Heska” or the “Company”) completed its previously announced acquisition (“Acquisition”) of 100% of the capital stock of scil animal care company GmbH (“scil”) from Covetrus Animal Health Holdings Limited (the “Seller”), a subsidiary of Covetrus, Inc. (“Covetrus”), pursuant to the terms and conditions of the agreement regarding the sale and purchase of the sole share of scil, dated as of January 14, 2020, as amended by the amendment agreement dated as of April 1, 2020, by and among the Company, Heska GmbH, a subsidiary of the Company, Covetrus, the Seller and Covetrus Financing Holding, Ltd.
Set forth below are the unaudited pro forma condensed combined balance sheet as of December 31, 2019 and the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2019 (together with the notes to the unaudited pro forma financial statements, the “pro forma financial statements”), that have been derived from the historical consolidated financial statements of Heska and scil after giving pro forma effect to the Acquisition. The unaudited pro forma combined financial information should be read in conjunction with the accompanying notes to the unaudited pro forma combined financial statements. In addition, the unaudited pro forma financial statements should be read in conjunction with the audited consolidated financial statements of Heska and the audited combined financial statements of scil and its subsidiaries, as of and for the year ended December 31, 2019.
The unaudited pro forma condensed combined balance sheet is presented as if the Acquisition took place as of December 31, 2019. The unaudited pro forma condensed combined statement of operations for the year ended December 31, 2019 is presented as if the Acquisition occurred on January 1, 2019.
The unaudited pro forma combined financial information has been prepared using the acquisition method of accounting under the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) Topic 805, Business Combinations (“ASC 805”). The purchase price will be allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the acquisition date, and any excess value of the consideration transferred over the net assets will be recognized as goodwill. The Company has made a preliminary allocation of the purchase price to the assets acquired and liabilities assumed as of the assumed acquisition date of December 31, 2019 based on management’s preliminary estimate of the fair value of tangible and intangible assets acquired and liabilities assumed using information currently available. Each of the adjustments is preliminary and is based on certain estimates and currently available information and is subject to further adjustments as additional information becomes available and as additional analyses are performed. Management believes that all significant adjustments necessary to reflect the effects of the Acquisition are included in the accompanying unaudited pro forma financial statements and are deemed to be reasonable. As the final valuations are performed, increases or decreases in the fair value of relevant balance sheet amounts and their useful lives will result in adjustments, which may be material to the balance sheet and/or the statement of operations.
The preliminary unaudited pro forma purchase price allocation has been made solely for the purpose of preparing the accompanying unaudited pro forma financial statements. The unaudited pro forma financial statements are not necessarily indicative of what the actual consolidated financial position or results of operations of Heska and scil would have been as of and for the periods presented, nor does it purport to represent the future consolidated financial position or results of operations of Heska and scil.
The unaudited pro forma financial statements do not reflect the impact of any potential cost savings, operating synergies or efficiencies that the combined company may achieve as a result of the acquisition, nor the costs that may be incurred to achieve such benefits.



HESKA CORPORATION AND SUBSIDIARIES
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
AS OF DECEMBER 31, 2019
(in thousands)
 
 
 
 
scil
 
Pro Forma
 
 
 
Pro Forma
 
 
Heska
 
As Adjusted (i)
 
Adjustments
 
Note
 
Combined
ASSETS
Current assets:
 
 

 
 

 
 
 
 
 
 
Cash and cash equivalents
 
$
89,030

 
$
6,458

 
$
10,759

 
(A,H)
 
$
106,247

Accounts receivable, net
 
15,161

 
11,404

 
(279
)
 
(E)
 
26,286

Inventories, net
 
26,601

 
11,641

 
(268
)
 
(I)
 
37,974

Net investment in leases, current, net
 
3,856

 
292

 

 
 
 
4,148

Prepaid expenses
 
2,219

 
945

 

 
 
 
3,164

Other current assets
 
3,000

 
195

 

 
 
 
3,195

Total current assets
 
139,867

 
30,935

 
10,212

 
 
 
181,014

 
 
 
 
 
 
 
 
 
 
 
Property and equipment, net
 
15,469

 
15,438

 
3,935

 
(B)
 
34,842

Operating lease right-of-use assets
 
5,726

 
964

 

 
 
 
6,690

Goodwill
 
36,204

 
6,141

 
39,502

 
(C)
 
81,847

Other intangible assets, net
 
11,472

 
3,611

 
40,656

 
(D)
 
55,739

Deferred tax asset, net
 
6,429

 
627

 

 
 
 
7,056

Net investment in leases, non-current
 
14,307

 
1,062

 

 
 
 
15,369

Investments in unconsolidated affiliates
 
7,424

 
42

 
13

 
(L)
 
7,479

Other non-current assets
 
7,526

 
314

 

 
 
 
7,840

Total assets
 
$
244,424

 
$
59,134

 
$
94,318

 
 
 
$
397,876

 
 
 
 
 
 
 
 
 
 
 
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY
Current liabilities:
 
 

 
 

 
 
 
 
 
 
Accounts payable
 
$
6,600

 
$
9,494

 
$
(279
)
 
(E)
 
$
15,815

Accrued liabilities
 
6,345

 
4,568

 

 
 
 
10,913

Accrued purchase consideration payable
 
14,579

 

 

 
 
 
14,579

Current operating lease liabilities
 
1,745

 
373

 

 
 
 
2,118

Current portion of deferred revenue, and other
 
2,930

 
3,016

 
52

 
(K)
 
5,998

Total current liabilities
 
32,199

 
17,451

 
(227
)
 
 
 
49,423

 
 
 
 
 
 
 
 
 
 
 
Convertible note, long-term, net
 
45,348

 

 

 
 
 
45,348

Deferred revenue, net of current portion
 
5,966

 
226

 
8

 
(K)
 
6,200

Other long-term borrowings
 
1,121

 

 

 
 
 
1,121

Non-current operating lease liabilities
 
4,413

 
597

 

 
 
 
5,010

Deferred tax liability
 
691

 
1,789

 
11,534

 
(F)
 
14,014

Other liabilities
 
152

 
288

 

 
 
 
440

Total liabilities
 
89,890

 
20,351

 
11,315

 
 
 
121,556

 
 
 
 
 
 
 
 
 
 
 
Redeemable non-controlling interest and mezzanine equity
 
170

 

 

 
 
 
170

 
 
 
 
 
 
 
 
 
 
 
Stockholders' equity:
 
 

 
 

 
 
 
 
 
 
Preferred stock
 

 

 
1

 
(H)
 
1

Original common stock
 

 

 

 
 
 

Public common stock
 
79

 

 

 
 
 
79

Additional paid-in capital
 
290,216

 

 
121,785

 
(H)
 
412,001

Net parent investment
 

 
38,886

 
(38,886
)
 
(J)
 

Accumulated other comprehensive income (loss)
 
513

 
(103
)
 
103

 
(J)
 
513

Accumulated deficit
 
(136,444
)
 

 

 
 
 
(136,444
)
Total stockholders' equity
 
154,364

 
38,783

 
83,003

 
 
 
276,150

Total liabilities, mezzanine equity and stockholders' equity
 
$
244,424

 
$
59,134

 
$
94,318

 
 
 
$
397,876

(i)  
Refer to Note 4 for additional details regarding reclassifications and currency conversion to conform with that of Heska Corporation.

See notes to the unaudited pro forma condensed combined financial statements.




HESKA CORPORATION AND SUBSIDIARIES
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
YEAR ENDED DECEMBER 31, 2019
(in thousands, except per share amounts)
 
 
 
 
scil
 
Pro Forma
 
 
 
Pro Forma
 
 
Heska
 
As Adjusted (i)
 
Adjustments
 
Note
 
Combined
Revenue:
 
 

 
 

 
 

 
 
 
 
Core companion animal
 
$
106,570

 
$
81,212

 
$
(2,008
)
 
(E)
 
$
185,774

Other vaccines and pharmaceuticals
 
16,091

 

 

 
 
 
16,091

Total revenue, net
 
122,661

 
81,212

 
(2,008
)
 
 
 
201,865

 
 
 
 
 
 
 
 
 
 
 
Cost of revenue
 
68,212

 
55,927

 
(1,824
)
 
(B,D,E)
 
122,315

 
 
 
 
 
 
 
 
 
 
 
Gross profit
 
54,449

 
25,285

 
(184
)
 
 
 
79,550

 
 
 
 
 
 
 
 
 
 
 
Operating expenses:
 
 

 
 

 
 

 
 
 
 
Selling and marketing
 
27,678

 
13,414

 
2,312

 
(B,D)
 
43,404

Research and development
 
8,240

 

 

 
 
 
8,240

General and administrative
 
18,204

 
11,359

 
(185
)
 
(B,G)
 
29,378

Total operating expenses
 
54,122

 
24,773

 
2,127

 
 
 
81,022

Operating income
 
327

 
512

 
(2,311
)
 
 
 
(1,472
)
Interest and other expense (income), net
 
2,910

 
140

 

 
 
 
3,050

(Loss) income before income taxes and equity in losses of unconsolidated affiliates
 
(2,583
)
 
372

 
(2,311
)
 
 
 
(4,522
)
Income tax (benefit) expense:
 
 

 
 

 
 

 
 
 
 
Current income tax expense
 
359

 
243

 

 
 
 
602

Deferred income tax (benefit) expense
 
(1,805
)
 
(453
)
 
(626
)
 
(F)
 
(2,884
)
Total income tax (benefit) expense
 
(1,446
)
 
(210
)
 
(626
)
 
 
 
(2,282
)
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income before equity in losses of unconsolidated affiliates
 
(1,137
)
 
582

 
(1,685
)
 
 
 
(2,240
)
Equity in losses of unconsolidated affiliates
 
(594
)
 

 

 
 
 
(594
)
Net (loss) income, after equity in losses of unconsolidated affiliates
 
(1,731
)
 
582

 
(1,685
)
 
 
 
(2,834
)
Net loss attributable to non-controlling interest
 
(266
)
 

 

 
 
 
(266
)
Net (loss) income attributable to Heska Corporation
 
$
(1,465
)
 
$
582

 
$
(1,685
)
 
 
 
$
(2,568
)
 
 
 
 
 
 
 
 
 
 
 
Basic (loss) earnings per share attributable to Heska Corporation
 
$
(0.20
)
 
$

 
$

 
 
 
$
(0.34
)
Diluted (loss) earnings per share attributable to Heska Corporation
 
$
(0.20
)
 
$

 
$

 
 
 
$
(0.34
)
 
 
 
 
 
 
 
 
 
 
 
Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation
 
7,446

 

 

 
 
 
7,446

Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation
 
7,446

 

 

 
 
 
7,446

(i)  
Refer to Note 4 for additional details regarding reclassifications and currency conversion to conform with that of Heska Corporation.

See notes to the unaudited pro forma condensed combined financial statements.





HESKA CORPORATION AND SUBSIDIARIES
NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
(In thousands of dollars, except per share data and share amounts)
1.
Basis of Presentation
The accompanying unaudited pro forma financial statements were prepared in accordance with Article 11 of Regulation S-X using the acquisition method of accounting under U.S. generally accepted accounting principles and are based on the historical consolidated and combined financial information of Heska and scil. The historical financial information has been adjusted to give pro forma effect to events that are: (i) directly attributable to the Acquisition, (ii) factually supportable, and (iii) with respect to the unaudited pro forma statements of operations, expected to have a continuing impact. The pro forma adjustments are preliminary and based on estimates of the purchase consideration and estimates of fair value and useful lives of the assets acquired and liabilities assumed.
The unaudited pro forma condensed combined balance sheet (“pro forma balance sheet”) is presented “as if” the Acquisition had occurred on December 31, 2019. The unaudited pro forma condensed combined statement of operations (“pro forma statement of operations”) for the year ended December 31, 2019 is presented “as if” the Acquisition had occurred on January 1, 2019, representing the beginning of the earliest period presented.
Heska performed certain procedures for the purpose of identifying material differences in significant accounting policies between Heska and scil and any accounting policy alignment adjustments that would be required in order to conform scil’s historical financial statements to Heska’s financial statement presentation. Procedures performed by Heska involved a review of scil’s summary of significant accounting policies, including those disclosed in scil’s audited financial statements in Exhibit 99.2 and preliminary discussion with scil management regarding scil’s significant accounting policies to identify material differences. The historical combined financial statements of scil were prepared in euros, and therefore, have been translated to U.S. dollars to conform with Heska’s financial statement presentation. Refer to Note 4 - Accounting Policy Alignment and Reclassifications for more details.
2.
Purchase Price Allocation
The Acquisition has been accounted for using the acquisition method of accounting in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). ASC 805 requires, among other things, that assets acquired and liabilities assumed be recognized at their fair values, as determined in accordance with ASC 820, Fair Value Measurements, as of the Acquisition date. Under the acquisition method of accounting, the assets acquired and liabilities assumed are recorded at the effective date of the Acquisition at their respective fair values and added to those of Heska.
The total purchase consideration of $111,027 was paid in cash and was allocated to the pro forma assets acquired and liabilities assumed based on a preliminary estimate of their fair values as if the Acquisition had taken place on December 31, 2019. The total purchase consideration is subject to customary working capital adjustments.




The information below represents the preliminary purchase price allocation of scil:
 
 
Total purchase consideration
$
111,027

Current assets, including cash acquired
19,294

Inventories, net
11,373

Property and equipment, net
19,373

Other intangible assets, net
44,267

Deferred tax asset, net
627

Investments in unconsolidated affiliates
55

Other assets
2,340

     Total assets
97,329

Current liabilities
16,468

Current portion of deferred revenue
1,035

Deferred revenue, net of current portion
234

Deferred tax liability
13,323

Other liabilities
885

     Net assets acquired
$
65,384

Goodwill
$
45,643

As indicated above, Heska has made preliminary purchase price allocations based on currently available information. The final determination of the fair value of the assets acquired and liabilities assumed is expected to be completed as soon as practicable.
The amounts allocated to assets acquired and liabilities assumed in the Acquisition could differ materially from the preliminary amounts presented in these unaudited pro forma financial statements. A decrease in the fair value of assets acquired or an increase in the fair value of liabilities assumed in the Acquisition from those estimates presented in these unaudited pro forma financial statements would result in a corresponding increase in the amount of Goodwill from the Acquisition. In addition, if the value of the acquired assets is higher or lower than indicated, it may result in higher or lower amortization and depreciation expense than is presented in these unaudited pro forma financial statements.
3.
Pro Forma Adjustments
Adjustments included in the columns labeled “Pro Forma Adjustments” in the unaudited pro forma financial statements are as follows:
(A) Represents the adjustment for cash consideration of approximately $111,027 paid to effect the Acquisition.




(B) Represents the preliminary estimated fair value adjustment to Property and equipment to reflect the preliminary fair market value and related depreciation expense, calculated on a straight-line basis:
 
Preliminary Fair Value
 
Useful Life (years)
 
Depreciation Expense
Year Ended December 31, 2019
Land
$
2,042

 
n/a
 
$

Building
6,630

 
28.1
 
236

Machinery and Equipment
8,858

 
3.8
 
2,344

Office furniture and equipment
440

 
2.2
 
196

Computer hardware and software
1,031

 
1.8
 
558

Leasehold and building improvements
372

 
8.3
 
45

     Total
19,373

 
 
 
3,379

Less: scil historical Property and equipment, net and depreciation expense
15,438

 
 
 
2,807

Pro forma adjustment
$
3,935

 
 
 
$
572

Adjustment to Cost of revenue
 
 
 
 
96

Adjustment to Selling and marketing expense
 
 
 
 
(13
)
Adjustment to General and administrative expense
 
 
 
 
489

With other assumptions held constant, a 10% increase in fair value for Property and equipment would increase annual pro forma depreciation expense by approximately $338.
(C) Reflects the estimated adjustment to Goodwill as a result of the Acquisition:
Preliminary purchase price
$
111,027

Less: estimated fair value of net assets acquired
65,384

     Total estimated Goodwill
45,643

Less: scil historical Goodwill
6,141

Pro forma adjustment
$
39,502

(D) Reflects the preliminary estimated fair value adjustment to recognize identifiable intangible assets and related amortization expense, calculated on a straight-line basis:
 
Preliminary Fair Value
 
Useful Life (years)
 
Amortization Expense
Year Ended December 31, 2019
Customer relationships
$
36,095

 
10

 
$
3,610

Non-compete agreement
59

 
2

 
30

Internally developed software
350

 
3-5

 
88

Trademarks and trade names
7,489

 
n/a

 

Trademarks (Canada)
66

 
0.8

 
66

Backlog
208

 
0.2

 
208

     Total
44,267

 
 
 
4,001

Less: scil historical Other intangible assets, net, and amortization expense
3,611

 
 
 
1,588

Pro forma adjustment
$
40,656

 
 
 
$
2,413

Adjustment to Cost of revenue
 
 
 
 
88

Adjustment to Selling and marketing expense
 
 
 
 
2,325





With other assumptions held constant, a 10% increase in the fair value for amortizable intangible assets would increase annual pro forma amortization by approximately $1,568.
(E) Represents the adjustment to eliminate intercompany transactions of $2,008 in core companion animal revenue and cost of revenue between Heska and scil during the year ended December 31, 2019, as well as the $279 in accounts payable and accounts receivable for the respective companies as of December 31, 2019.
(F) Represents the adjustment for estimated deferred income tax expense and estimated deferred tax liability to adjust for the estimated effects of combining Heska’s and scil’s operations and the impact of pre-tax pro forma adjustments, based on the blended scil statutory tax rate of 27.11%.
(G) Represents the adjustment to remove transaction costs of $674 included in the historical financial statements that will not be recurring.
(H) Represents the adjustment to record the cash proceeds of $121,786, net of offering cost of $214 from the issuance of 122,000 shares of Series X Convertible Preferred Stock on March 30, 2020 at a price of $1,000 per share and par value of $0.01 per share, the net proceeds from which were used to finance the Acquisition. Preferred shares do not participate in the loss and therefore, were not included in the calculation of basic EPS. Preferred shares were not included in calculation of diluted EPS due to the net loss position.
(I) Represents the adjustment to step-down Inventories to its estimated fair value based on the preliminary purchase price allocation.
(J) Represents the adjustment to eliminate scil historical equity as part of the Acquisition purchase price allocation.
(K) Represents the adjustment to Deferred revenue to its estimated fair value based on the preliminary purchase price allocation.
(L) Represents the adjustment to step-up the Investment in unconsolidated affiliates to its estimated fair value based on the preliminary purchase price allocation.
4.    Accounting Policy Alignment and Reclassifications
The historical combined financial statements of scil were prepared in accordance with U.S. GAAP and reported in euros. The historical combined financial information of scil presented in the unaudited pro forma condensed combined financial information has been translated to U.S. dollars. The foreign currency rates used to convert the historical combined financial statements to U.S. dollars are presented below.
Based upon the available information, Heska did not identify accounting policy differences that would have a material impact on the unaudited pro forma condensed combined financial data and therefore no pro forma adjustments were necessary. Heska will continue reviewing scil’s accounting policies in more detail. As a result of that review, Heska may identify differences between the accounting policies of the companies that, when conformed, could have a material impact on the unaudited pro forma condensed combined financial data.
Certain historical financial statement line items of scil were reclassified in order to conform to Heska’s presentation as follows:




SCIL ANIMAL CARE COMPANY GMBH
COMBINED BALANCE SHEET
AS OF DECEMBER 31, 2019
(in thousands)
 
 
 
 
 
 
Heska
 
Heska
 
 
 
 
 
 
Classification
 
Classification
 
 
scil (EUR)
 
Reclassifications
 
(EUR)
 
(USD)(i)
ASSETS
Current assets:
 
 

 
 

 
 
 
 
Cash and cash equivalents
 
5,758

 

 
5,758

 
$
6,458

Accounts receivable, net
 
10,168

 

 
10,168

 
11,404

Inventories, net
 
10,379

 

 
10,379

 
11,641

Net investment in leases, current, net
 

 
260

 
260

 
292

Prepaid expenses
 
1,277

 
(434
)
 
843

 
945

Other current assets
 

 
174

 
174

 
195

Total current assets
 
27,582

 

 
27,582

 
30,935

 
 
 
 
 
 
 
 
 
Property and equipment, net
 
14,624

 
(859
)
 
13,765

 
15,438

Operating lease right-of-use assets
 

 
859

 
859

 
964

Goodwill
 
5,475

 

 
5,475

 
6,141

Other intangible assets, net
 
3,220

 

 
3,220

 
3,611

Deferred tax asset, net
 

 
559

 
559

 
627

Net investment in leases, non-current
 

 
947

 
947

 
1,062

Investments in unconsolidated affiliates
 

 
38

 
38

 
42

Other non-current assets
 
1,824

 
(1,544
)
 
280

 
314

Total assets
 
52,725

 

 
52,725

 
$
59,134

 
 
 
 
 
 
 
 
 
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY
Current liabilities:
 
 

 
 

 
 
 
 
Accounts payable
 
8,465

 

 
8,465

 
$
9,494

Accrued liabilities
 
2,373

 
1,700

 
4,073

 
4,568

Current operating lease liabilities
 

 
333

 
333

 
373

Current portion of deferred revenue, and other
 

 
2,689

 
2,689

 
3,016

Other liabilities
 
4,722

 
(4,722
)
 

 

Total current liabilities
 
15,560

 

 
15,560

 
17,451

 
 
 
 
 
 
 
 
 
Deferred revenue, net of current portion
 

 
201

 
201

 
226

Non-current operating lease liabilities
 

 
533

 
533

 
597

Deferred tax liability
 

 
1,595

 
1,595

 
1,789

Other liabilities
 
2,586

 
(2,329
)
 
257

 
288

Total liabilities
 
18,146

 

 
18,146

 
20,351

 
 
 
 
 
 
 
 
 
Net parent investment
 
34,671

 

 
34,671

 
38,886

Accumulated other comprehensive income (loss)
 
(92
)
 

 
(92
)
 
(103
)
Total stockholders' equity
 
34,579

 

 
34,579

 
38,783

Total liabilities and stockholders' equity
 
52,725

 

 
52,725

 
$
59,134

(i)  
Euro amounts are converted to U.S. Dollars at an exchange rate of 1.1216 for the balance sheet as of December 31, 2019.






SCIL ANIMAL CARE COMPANY GMBH
COMBINED STATEMENT OF OPERATIONS
FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2019
(in thousands)
 
 
 
 
 
 
Heska
 
Heska
 
 
 
 
 
 
Classification
 
Classification
 
 
scil (EUR)
 
Reclassifications
 
(EUR)
 
(USD)(i)
Revenue:
 
 

 
 

 
 

 
 
Net Sales
 
72,532

 
(72,532
)
 

 
$

Core companion animal
 

 
72,532

 
72,532

 
81,212

Total revenue, net
 
72,532

 

 
72,532

 
81,212

 
 
 
 
 
 
 
 
 
Cost of revenue
 

 
(49,950
)
 
49,950

 
55,927

Cost of sales
 
(49,950
)
 
49,950

 

 

Gross profit
 
22,582

 

 
22,582

 
25,285

 
 
 
 
 
 
 
 
 
Operating expenses:
 
 

 
 

 
 

 
 
Selling, general and administrative
 
(22,125
)
 
22,125

 

 

Selling and marketing
 

 
(11,980
)
 
11,980

 
13,414

General and administrative
 

 
(10,145
)
 
10,145

 
11,359

Total operating expenses
 
(22,125
)
 

 
22,125

 
24,773

Operating income
 
457

 

 
457

 
512

Interest and other expense (income), net
 

 
(125
)
 
125

 
140

Other income (expense)
 
(125
)
 
125

 

 

(Loss) income before income taxes and equity in losses of unconsolidated affiliates
 
332

 

 
332

 
372

Income tax (benefit) expense:
 
 

 
 

 
 

 
 
Income tax benefit
 
188

 
(188
)
 

 

Current income tax expense
 

 
(217
)
 
217

 
243

Deferred income tax (benefit) expense
 

 
405

 
(405
)
 
(453
)
Total income tax (benefit) expense
 
188

 

 
(188
)
 
(210
)
 
 
 
 
 
 
 
 
 
Net income
 
520

 

 
520

 
$
582

(i)  
Euro amounts are converted to U.S. Dollars at an average exchange rate of 1.1197 for the statement of operations for the year ended December 31, 2019.